Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers
Authors' conclusion
The tubeless AID system was associated with significant improvements in a number of psychosocial outcomes for children, adolescents, and their caregivers.
Study context
- Population
- Children and adolescents with T1D and their caregiversplus caregivers
- Participants
- 83 vs 42
- Exposure
- Psychosocial outcomes before vs after 3 months of tubeless automated insulin delivery (AID) use
- Childrenn = 83
- Adolescentsn = 42
- Outcome
- Changes in psychosocial outcomes: diabetes distress (PAID), hypoglycemia confidence (HCS), well-being (WHO-5), sleep quality (PSQI), insulin delivery satisfaction (IDSS) and system usability (SUS)
- Follow-up
- Before and after 3 months of AID use
Methodological detailsmulticenter
- Multicenter
Main finding
As reported in the abstract
Psychosocial outcomes · 3 months
- Improvements for children, adolescents and/or caregivers in diabetes-related distress, insulin delivery satisfaction and system usability (all P < 0.05)
- Caregivers of children: improved general well-being, confidence in managing hypoglycemia and sleep quality (all P < 0.05)
Observational data: associations, not effects.
Further findings
Associations with baseline characteristics and glycemic outcomes
- Improvements in psychosocial outcomes generally independent of baseline characteristics and changes in glycemic outcomes
- Linear regression analyses
Original publication
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. Pediatr Diabetes. Published 29 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →